创伤中心临终关怀使用差异可能影响老年创伤结局分析:基于2017至2019年2317家机构1961228例住院的分析
本研究利用2017至2019年美国联邦医疗保险与医疗补助服务中心住院标准分析文件,纳入65岁及以上、至少有一个损伤相关ICD-10编码、所在医院年创伤患者≥50例的住院病例,共1.96百万例住院、2317家医院。将临终关怀出院与住院死亡合并定义为总死亡,比较不同创伤中心级别的临终关怀出院率,并用优势分析识别影响临终关怀使用的因素。结果显示,I级中心的粗临终关怀出院率显著低于II级和III级中心,但调整后I级中心低于所有其他机构类型;临终关怀出院占总死亡的比例在I级中心最低(0.38)。作者认为临终关怀出院率应纳入医院结局的死亡率评估,并需进一步研究以优化老年创伤临终决策中临终关怀的使用。
要点
- 调整后I级创伤中心临终关怀出院率最低(0.026),低于II级(0.031)、III级(0.034)、IV级(0.033)和非创伤中心(0.030),差异有统计学意义(p < 0.05)。
- 粗临终关怀出院率I级(0.030)显著低于II级(0.035)和III级(0.035)(p < 0.05),但与IV级(0.032)和非创伤中心(0.030)无显著差异(p > 0.05)。
- 临终关怀出院占总死亡的比例随创伤中心级别变化,I级中心最低(0.38)。
- 优势分析显示,损伤严重度评分>15的患者比例对临终关怀使用率解释贡献最大(3.2%),其次为创伤中心级别(2.3%)、白人比例(1.9%)、女性比例(1.5%)和城乡环境(1.4%)。
- 作者认为应将临终关怀出院纳入医院结局的死亡率评估,并需进一步研究以优化老年创伤临终决策中临终关怀的使用。
适用人群与场景
- 2017至2019年联邦医疗保险与医疗补助服务中心住院标准分析文件中65岁及以上、至少有一个损伤相关ICD-10编码、所在医院年创伤患者≥50例的住院患者。
- 纳入医院包括I级(10%)、II级(14%)、III级(18%)、IV级(7%)和非创伤中心(51%)。
研究设计与关键结果
- 研究类型为基于联邦医疗保险与医疗补助服务中心住院标准分析文件的近全人群分析,纳入2017至2019年1.96百万例住院、2317家医院。
- 粗临终关怀出院率:I级0.030、II级0.035、III级0.035、IV级0.032、非创伤中心0.030;I级显著低于II级和III级(p < 0.05),与IV级和非创伤中心无显著差异(p > 0.05)。
- 调整后临终关怀出院率:I级0.026、II级0.031、III级0.034、IV级0.033、非创伤中心0.030;I级低于所有其他机构类型(p < 0.05)。
- 临终关怀出院占总死亡的比例随创伤中心级别变化,I级中心最低(0.38)。
- 优势分析:损伤严重度评分>15的患者比例贡献最大(3.2%),其次为创伤中心级别(2.3%)、白人比例(1.9%)、女性比例(1.5%)、城乡环境(1.4%)。
证据类型、等级与局限
- 证据类型:基于行政数据库的分析;证据等级:治疗/照护管理;Level II。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,临终关怀出院率随创伤中心级别显著变化,应纳入医院结局的死亡率评估。
- 作者认为,随着人口老龄化,准确评估老年创伤结局变得更加关键;需进一步研究以评估老年创伤临终决策中临终关怀的最佳使用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Defining discharges to hospice as "deaths" is vital for properly assessing trauma center outcomes. This is critical with older patients as a higher proportion is discharged to hospice. The goals of this study were to measure rates of hospice use, evaluate hospice discharge rates by trauma center level, and identify variables affecting hospice use in geriatric trauma.
METHODS: Patients from the Centers for Medicare and Medicaid Services Inpatient Standard Analytical Files for 2017 to 2019, 65 years or older, with ≥1 injury International Classification of Diseases, Tenth Revision , code, at hospitals with ≥50 trauma patients per year were selected. Total deaths was defined as inpatient deaths plus hospice discharges. Dominance analysis identified the most important contributors to a model of hospice use.
RESULTS: A total of 1.96 million hospitalizations from 2,317 hospitals (Level I, 10%; II, 14%; III, 18%; IV, 7%; none, 51%) were included. Level I's had significantly lower raw hospice discharge values compared with Levels II and III (I, 0.030; II, 0.035; III, 0.035; p < 0.05) but not Level IV (0.032) or nontrauma centers (0.030) ( p > 0.05). Adjusted Level I hospice discharge rates were lower than all other facility types (Level I, 0.026; II, 0.031; III, 0.034; IV, 0.033; nontrauma, 0.030; p < 0.05). Hospice discharges as a proportion of total deaths varied by level and were lowest (0.38) at Level I centers. Dominance analysis showed that proportion of patients with Injury Severity Score of >15 contributed most to explaining hospice utilization rates (3.2%) followed by trauma center level (2.3%), proportion White (1.9%), proportion female (1.5%), and urban/rural setting (1.4%).
CONCLUSION: In this near population-based geriatric trauma analysis, Level I centers had the lowest hospice discharge rate, but hospice discharge rates varied significantly by trauma level and should be included in mortality assessments of hospital outcomes. As the population ages, accurate assessment of geriatric trauma outcomes becomes more critical. Further studies are needed to evaluate the optimal utilization of hospice in end-of-life decision making for geriatric trauma.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level II.
参考来源
- Fakhry SM, Shen Y, Wyse RJ, et al. Variation in hospice use among trauma centers may impact analysis of geriatric trauma outcomes: An analysis of 1,961,228 Centers for Medicare and Medicaid Services hospitalizations from 2,317 facilities. J Trauma Acute Care Surg. 2023. PMID: 36653910. doi:10.1097/TA.0000000000003883
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。